a critical period for brain copper acquisition in the developing fetus (32) . The role of copper in CNS development is dramatically revealed in Menkes disease, a fatal neurodegenerative disorder of early childhood due to inherited loss-of-function mutations in the gene encoding ATP7A, a copper-transporting P-type ATPase essential for cellular copper homeostasis (16) . This ATPase resides in the trans-Golgi network and functions to transport copper into the secretory pathway for incorporation into specific cuproenzymes (29) and export from the cell (28) . The pleiotropic features of Menkes disease include growth failure, brittle hair, hypopigmentation, arterial tortuosity, and neurodegeneration, which arise from impaired activity of specific cuproenzymes secondary to systemic copper deficiency resulting from the loss of ATP7A-dependent copper transport across the placenta, intestinal epithelium (45) , and bloodcerebrospinal fluid barrier (8) .
The neurological features of Menkes disease are present in early infancy, when magnetic resonance imaging demonstrates impaired myelination with cerebellar and cerebral atrophy and pathological examination reveals focal degeneration of the gray matter and neuronal loss prominent in the hippocampus and cerebellum (23, 34, 43) . This same neuropathology and early neurological symptoms are also observed in the mottled brindle (mo-br) mouse mutant and other "mottled" variants that harbor naturally occurring mutations in the Atp7a gene (35) . Despite extensive studies, the mechanisms of neurodegeneration in Menkes disease remain unknown and are not explained by impaired activity of any of the known cuproenzymes. ATP7A is expressed in the epithelial cells of the choroid plexus and in specific populations of neurons and glia in several brain regions, including the cerebellum and hippocampus. Studies in mo-br mice demonstrate a role for ATP7A in axon extension and synaptogenesis during development (10) . In hippocampal neurons, ATP7A mediates an NMDA receptor-dependent releasable pool of copper, and the absence of this function in mo-br mice markedly accentuates NMDA receptor-mediated excitotoxicity in these neurons (36, 37) .
Treatment with systemic copper is ineffective in Menkes disease, revealing that ATP7A is essential for copper transport into the CNS. However, rarely do patients with minimal residual ATP7A activity have no neurodegeneration, despite systemic signs and symptoms, revealing preferential distribution to the brain under circumstances of limited copper availability, a concept supported in a zebrafish model of Menkes disease (24) . Importantly, these patients demonstrate further neurodevelopmental improvement when treated with copper (16), suggesting a role for systemic copper homeostasis in neurological outcome. To directly assess the role of CNS ATP7A in neuronal development and function, we have generated a mouse model (Atp7a Nes ) in which the Atp7a gene is selectively deleted in neural precursor cells. Importantly, these mice retain functional ATP7A expression in all other systemic cell types, including the choroid plexus, thus permitting a direct assessment of the role of ATP7A within the brain.
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MATERIALS AND METHODS
Animals. All animal husbandry and euthanasia procedures were approved by the Animal Care and Use Committee of the University of Missouri. All mice were on the C57BL6 strain background. Mice were housed in vented cages with a 12:12-h light-dark cycle, and food and water were provided ad libitum.
Generation of wild-type and Atp7a
Nes mice. Floxed mice were generated as previously described (45) . To generate the Nestin-Cremediated deletion of Atp7a (Atp7a Nes ), heterozygous floxed females (Atp7a fl/ϩ ) were crossed with Nes (Nes-cre)1Kln /J males (Jackson Laboratory, Bar Harbor, ME). Male offspring that were Cre-positive but lacked the floxed Atp7a allele were used as wild-type (WT) controls. Tail biopsies from offspring were genotyped by PCR as previously described (44, 45) . Immunoblot analysis. Tissue samples were homogenized in icecold phosphate-buffered saline at pH 7.4, and protein lysates were prepared by sonication of cell pellets in lysis buffer containing 62.5 mM Tris·HCl (pH 7.4), 2% SDS, 1% Triton X-100, 1 mM EDTA, and cOmplete protease inhibitor (Roche Molecular Biochemicals, Indianapolis, IN). Protein lysates were fractionated by 7.5% SDS-PAGE and transferred onto nitrocellulose membranes. ATP7A and actin were detected as previously described (44, 45) .
Tissue histology. Anesthetized mice were transcardially perfused with 4% paraformaldehyde. Tissues were removed, postfixed for 16 h in 4% paraformaldehyde at 4°C, and cryoprotected for 16 h in 20% sucrose prior to generation of 10-m sections using a cryostat. Myelin was detected using the BrainStain imaging kit according the manufacturer's protocol (Life Technologies, Grand Island, NY). For tissue histology, 4-m paraffin sections were stained with hematoxylin and eosin (11) or antibodies against ATP7A and then with HRP-conjugated anti-rabbit antibodies (RADIL, Columbia, MO). Where indi- cated, the intensity of chromogenic staining of ATP7A in sections was measured using ImageJ analysis software (NIH, Bethesda, MD). Enzyme assays. Hemoglobin concentrations were determined spectrophotometrically as metcyanohemoglobin as previously described (31) . Superoxide dismutase 1 (SOD1) activity was determined spectrophotometrically as competitive inhibition of DBT-diformazan formation using a commercial kit (Trevigen, Gaithersburg, MD). Cytochrome c oxidase (CCO) activity was determined spectrophotometrically by the oxidation of ferrocytochrome c using a commercial kit (Sigma, St. Louis, MO).
Catecholamine metabolite analyses. Whole brain samples were weighed and homogenized in 5-10 volumes of 0.4 N perchloric acid containing 0.1% EDTA. Catecholamines were determined by highperformance liquid chromatography with electrochemical detection as previously described (8) .
Metal analysis. Tissue metal concentrations were measured by inductively coupled plasma mass spectrometry using a mass spectrometer (model 7500cx, Agilent) coupled to an autosampler (model SC-DX4, Elemental Scientific, Omaha, NE) with 50 ppb Ga as an internal standard. Tissue was dissolved in 70% nitric acid overnight at room temperature and then at 75°C for 2 h. Values were acquired in triplicate for each sample, and the results were normalized to tissue wet weight.
Primary cell culture of cortical neurons. Mouse primary cortical neurons (PCNs) were prepared as previously described with minor modifications (27) . Briefly, cerebral cortices from 17-day-old embryos of WT or Atp7a Nes mice were removed, and the meninges were discarded. The tissue was mechanically dissociated in high-glucose DMEM consisting of 10% (vol/vol) fetal bovine serum, 2 mM glutamine, 100 IU/ml penicillin, 100 mg/ml streptomycin, and 7.5 mg/ml amphotericin B (Fungizone). Tissue clumps were dispersed with a 10-ml pipette and suspended in 6 ml of 0.25% (wt/vol) trypsin at 37°C for 30 min. Heat-inactivated horse serum (2 ml) was added to neutralize trypsin activity, and the cell suspension was pelleted at 900 g. The cell pellet was suspended in high-glucose DMEM and filtered through a sterilized 75-m cell strainer (Becton Dickinson, Franklin Lakes, NJ), and the cells were seeded at 500 cells/mm 2 in plastic culture plates precoated with poly-D-lysine or poly-L-lysine (0.1 g/ml). After 16 -18 h and every 3 days thereafter, half of the medium was replaced with B27-AO Neurobasal medium (2 mM glutamine, 100 IU/ml penicillin, 100 mg/ml streptomycin, 7.5 mg/ml Fungizone, 10 ml of B27-AO, and Neurobasal medium to 500 ml). Neurons were cultured for 7 days prior to treatments. Positive microtubule-associated protein-2 staining was used to verify that the neuronal cultures were Ն95% pure. Nes mice, consistent with the lack of NestinCre-mediated deletion in this tissue. Scale bars ϭ 50 m. B: superoxide dismutase 1 (SOD1) activity in whole brain lysates from WT and Atp7a Nes mice at 3-4 mo of age. Values are means Ϯ SE; n ϭ 3. No significant differences were found. C: cytochrome c oxidase (CCO) activity in whole brain lysates from WT and Atp7a Nes mice at 3-4 mo of age. Values are means Ϯ SE; n ϭ 3. No significant differences were found. D: catecholamine biosynthetic pathway showing the location of copper-dependent dopamine-␤-hydroxylase (D␤H). E: catecholamine analysis in 2-mo-old WT and Atp7a
Nes mice. Dopamine (DA) was significantly increased in Atp7a
Nes mice compared with WT controls; however, there were no significant differences in dihydroxyphenylalanine (DOPA), dihydroxyphenylacetic acid (DOPAC), norepinephrine (NE), or dihydroxyphenylglycol (DHPG) levels. EPI, epinephrine. Error bars, SD; n ϭ 3. **P Ͻ 0.01 (by Student's t-test). Nes mice at 3-4 mo of age were intraperitoneally injected with NMDA (20 -100 mg/kg) or saline and video-monitored in an open chamber for 60 min. Seizure intensity was rated on a modified Racine scale from 0 (no behavioral alteration) to 6 (severe tonic-clonic seizures), assigned at 5-min intervals, as described previously (14) . Median, maximum, and total seizure scores were calculated. Brain histopathology following 24 h of recovery was analyzed via cresyl violet staining as previously described (46) .
Single-cell
Gait analysis. Gait was assessed using the Catwalk XT gait analysis system (Noldus Information Technology, Leesburg, VA). Mice were allowed to freely ambulate along an illuminated glass plate within a confined corridor, and footprints were recorded with a high-speed camera. Three compliant (time-constrained) trials were analyzed per animal and averaged, and the mean of the average was calculated per genotype (5) .
Rotarod analysis. Mice were trained over 3 consecutive days on a Rotarod treadmill (IITC Life Science, Woodland Hills, CA), with ramp speed increasing from 2.5 to 25 rpm over 180 s. On the 4th day, latency to fall (or until the mouse clasped onto the rod and began rotating with it) was recorded three times per mouse, with the longest duration used to generate mean scores for each age.
Open field test. All behavioral tests were performed during the light phase of the circadian cycle after 1 PM. All tests were performed in a semiblinded fashion, with the observer blind to genotype. For the open field test, mice were video-recorded in a Plexiglas square (72 cm 2 ) and allowed to freely ambulate for 15 min. Videos were analyzed in a semiblind fashion for number of squares entered with all four paws, number of times the central area (36 cm 2 ) was entered with all four paws, and time spent in the central area.
Statistical analyses. Values are means Ϯ SE. Statistical comparisons of control and experimental groups were performed using Student's t-test. P Ͻ 0.05 was considered significant.
RESULTS
Nestin-Cre-mediated deletion of Atp7a in mice. C57BL6 female mice carrying an X-linked floxed Atp7a gene (44, 45) were crossed with C57BL6 male mice expressing Cre recombinase from the Nestin gene promoter in which Cre recombinase is restricted to neuronal progenitor cells (neurons and Nes mice was comparable to that in WT mice. DAPI staining of the nuclei is shown in blue. Scale bars ϭ 50 m. Representative images are shown based on Ն3 mice for each genotype. neuroglia) from embryonic day 11 (42) . Hemizygous male progeny that inherited both the floxed Atp7a allele and the Nestin-Cre transgene, hereafter referred to as Atp7a Nes mice, were born at the expected Mendelian frequency. At birth, the Atp7a Nes mice were indistinguishable from WT littermates; however, within postnatal week 2 there was a noticeable growth defect in these animals (Fig. 1A) . Comparison of the Atp7a
Nes mice with the mo-br hemizygous mouse, in which the Atp7a gene is mutated in all cells, indicated a similar growth retardation (Fig. 1A) . However, the Atp7a Nes mice did not exhibit the coat color hypopigmentation observed in the mo-br mutant, which is known to arise from systemic copper deficiency in these animals (Fig. 1B) (13) . Consistent with previous studies of this mutant on the C57BL6 background (19), we found that the mo-br mice exhibited 100% mortality prior to weaning (Fig. 1B) . In contrast, most of the Atp7a Nes mice remained viable for Ն12 mo, with ϳ20% mortality by 3 mo of age (Fig. 1B) . The reduced size of the Atp7a
Nes mice was maintained in mature animals, remaining at ϳ50% of WT controls at the conclusion of this study at 1 yr of age (Fig. 1C) . Western blot analysis revealed a marked reduction in the levels of ATP7A protein in hippocampus, frontal cortex, and cerebellum of Atp7a
Nes mice relative to littermate control animals, consistent with extensive loss of ATP7A throughout the CNS (Fig. 1, D-F ). There were no changes in expression of the related transporter ATP7B in the brains of the Atp7a Nes mice, and no differences in ATP7A abundance were detected in a range of tissues outside the CNS (data not shown). As expected, copper concentrations in the brain at postnatal day 12 were lower in the mo-br mice in the cerebellum, frontal cortex, and hippocampus than in WT mice. However, no such copper deficiency was found in the brain of Atp7a Nes mice. In contrast, copper concentrations were normal (in cerebellum and frontal cortex) or slightly elevated (hippocampus) relative to WT mice (Fig. 1, G-I) . These data suggest that the early mortality and neurological symptoms of the mo-br mice are not associated with a deficiency of ATP7A per se but, rather, a deficiency of copper.
Copper entry from the blood into to the CNS is thought to involve ATP7A-mediated transport across the choroid plexus (4, 6, 26) , an epithelial barrier separating the cerebrospinal fluid from the blood. Consistent with normal-to-elevated copper levels in the Atp7a
Nes mouse brain, immunohistochemical analysis using anti-ATP7A antibodies revealed abundant staining of the ATP7A protein in the choroid plexus epithelial cells of Atp7a
Nes mice at postnatal day 12 and 4 mo of age ( Fig. 2A  and data not shown) . Analysis of staining intensity indicated that ATP7A abundance was 1.54 Ϯ 0.3 (SE) fold greater in the choroid plexus epithelial cells of Atp7a
Nes than WT mice (n ϭ 25 cells). The activities of the copper-dependent enzymes CCO (a mitochondrial enzyme) and SOD1 (a mitochondrial/cytoplasmic enzyme) were normal in the Atp7a
Nes mouse brain (Fig. 2, B and C) . Since one predicted function of ATP7A is delivery of copper into the secretory pathway to make copper 
(by Student's t-test). C and D: 3-mo-old WT and Atp7a
Nes mice. Atp7a Nes mice exhibit a Straublike tail phenotype. Note dorsiflexion of the tail in the Atp7a
Nes mouse (D). E: maximum seizure scores were recorded for WT and Atp7a
Nes mice on a modified Racine scale for 1 h following intraperitoneal injection with NMDA. Values are means Ϯ SE. *P Ͻ 0.05, ***P Ͻ 0.
(by Student's t-test). F: Atp7a
Nes mice exhibit greater NMDA-induced brain pathology than control animals. Mice at 3-4 mo of age were injected with NMDA (70 g/g body wt ip) to induce seizure activity. After a 24-h recovery, brains were sectioned and stained with cresyl violet. Note increase in dystrophic neurons in the dentate gyrus of Atp7a
Nes mice relative to control animals. Images represent Ն3 mice for each genotype. available to secreted copper-dependent enzymes, we also assessed catecholamine metabolite levels as an indirect measure of activity of dopamine-␤-hydroxylase (D␤H), a secreted copper-dependent enzyme that functions in the conversion of dopamine to norepinephrine (17) (Fig. 2D) . In agreement with a loss of ATP7A-dependent copper transport into the secretory pathway to D␤H, dopamine levels were significantly elevated in whole brain lysates derived from Atp7a
Nes mice compared with WT controls; however, other catecholamine metabolites were not affected (Fig. 2E) . These findings collectively suggest that the Atp7a
Nes mice provide a model of ATP7A loss-offunction within the brain, without the confounding variable of copper deficiency in this organ.
Atp7a Nes mice lack the neurodegenerative pathology of mo-br mice. We next investigated brain sections of Atp7a Nes mice and compared these with mo-br mice. Brains were harvested at postnatal day 12, the age at which mo-br mice typically exhibit marked neurological symptoms prior to lethality. As expected, the mo-br mice exhibited neurodegenerative features of Menkes disease, including pyknotic nuclei in the CA1 region of the hippocampus (Fig. 3A) and a loss of myelination in the cerebellum (Fig. 3B) . In contrast, no such defects were apparent in the brains of Atp7a
Nes mice (Fig. 3) . Taken together, these data are consistent with the concept that the early mortality and neuropathology in Menkes disease are the result of systemic copper deficiency and are not attributable to an intrinsic loss of ATP7A in the CNS.
Atp7a
Nes mice exhibit an increased sensitivity to NMDAinduced seizure. ATP7A mediates an NMDA receptor-dependent releasable pool of copper, and previous studies using primary hippocampal neurons cultured from mo-br mice suggest that the loss of ATP7A markedly accentuates NMDA receptor-mediated excitotoxicity in these neurons (36, 37) . We evaluated these findings in the context of PCNs isolated from the Atp7a Nes mice. No morphological or viability differences were noted in PCNs from WT and Atp7a
Nes mice. Stimulation of neurons from Atp7a
Nes mice with 50 M glutamate and 5 M glycine generated a significantly elevated peak [Ca 2ϩ ] i relative to neurons from WT mice, consistent with a role for ATP7A-dependent copper transport as a negative regulator of NMDA receptor activity (Fig. 4, A and B) . Whereas the mo-br mice are known to exhibit spontaneous seizure activity similar to that of patients with Menkes disease, we did not observe spontaneous seizure activity in the Atp7a Nes mice. However, mature Atp7a
Nes mice exhibited occasional dorsiflexion of the tail (Fig. 4, C and D) , suggesting that they may be susceptible to seizure (9) . To test this hypothesis, the seizure responses of WT and Atp7a
Nes mice were recorded following intraperitoneal Nes mice than by WT controls with 3-and 4-foot support and less time with diagonal support. Values are means Ϯ SE; n ϭ 8 per genotype. *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001 (by Student's t-test) . E: Rotarod analysis shows that latency to fall was decreased in Atp7a Nes mice at 3 mo of age compared with WT controls. Values are means Ϯ SE; n ϭ 8 per genotype. ***P Ͻ 0.001 (by 2-way ANOVA with Bonferonni's test).
injection of NMDA at three different concentrations. The Atp7a Nes mice exhibited a greater maximum seizure score than WT mice at three different doses of NMDA (Fig. 4E) . Histological analyses of brain sections taken 24 h after the highest NMDA dose revealed a marked increase in the presence of dystrophic neurons in the hippocampi of Atp7a
Nes mice that was concentrated in the dentate gyrus, suggesting that ATP7A is protective against NMDA receptor-induced excitotoxicity in vivo (Fig. 4F) .
Atp7a Nes mice exhibit additional neurological abnormalities. At 3-4 mo of age, Atp7a
Nes mice exhibited subtle defects in their gait (Fig. 5A ). There was a significant decrease in the frequency of simultaneous two-paw diagonal support in the Atp7a
Nes mice compared with control animals that was associated with a corresponding increase in the frequency of threeand four-foot simultaneous contacts (Fig. 5, B-D) . Consistent with impaired sensorimotor function, Rotarod assay showed a significantly reduced latency to fall in the Atp7a
Nes mice relative to WT mice (Fig. 5E ). Differences in exploratory activity were also observed between WT and Atp7a Nes mice exposed to an open field test (33) . A representative trace of the movements of the Atp7a
Nes and control mice during a 10-min testing period is shown in Fig. 6A . The Atp7a
Nes mice entered fewer squares overall (Fig. 6B ) and entered the central quadrant less frequently (Fig. 6C ) than control mice. Taken together, these data suggest that loss of ATP7A in the nervous system of Atp7a
Nes mice results in defects in motor activity and exploratory behavior.
DISCUSSION
Our study reveals that the Menkes-like degenerative neuropathology and early mortality in mo-br mice are not evident in the Atp7a
Nes mice, suggesting that such phenotypes are not attributable to loss of ATP7A function in the nervous system per se but, rather, to a defect in the transport of copper into the brain. Although we cannot exclude the possibility that residual amounts of ATP7A protein remaining in the CNS of Atp7a Nes mice may partially mitigate the severity of neurological defects (particularly in the presence of adequate copper entry to the brain), this appears unlikely to explain the phenotypic difference from the mo-br mouse, which retains small amounts of functional ATP7A protein and yet exhibits severe neurological defects (25) . Our findings support the concept that therapeutic approaches to prevent or ameliorate CNS pathology in affected patients should be directed at methods to deliver copper into the CNS, most likely at the earliest possible stages of development, and are consistent with previous data demonstrating that forced expression of ATP7A in the choroid plexus increases lifespan in mo-br mice (8) . The finding that hippocampal copper levels and ATP7A staining in the choroid plexus were slightly elevated in Atp7a
Nes mice suggests that ATP7A expression in the choroid plexus may be regulated by sequelae secondary to ATP7A deletion in the CNS, a finding that warrants further investigation. Taken together, our findings provide the first direct evidence that the degenerative neuropathology in mo-br mice is attributable to secondary copper deficiency and that these phenotypes can be delineated from those arising from loss of ATP7A in the nervous system. These data also reveal that the mechanisms of neurodegeneration are not entirely dependent on copper transport into the secretory pathway of neurons or glia, an observation that suggests that abnormalities in cytosolic or mitochondrial copper handling may contribute to this process. While CCO and SOD1 are known cuproenzymes within these compartments, the neurological phenotypes of loss-of-function of these enzymes do not fully explain the pathogenesis of neurodegeneration in Menkes disease (22, 38) .
The data reported here reveal unique and autonomous roles for ATP7A within the CNS. The phenotypes of growth impairment, motor defects, and reduced exploratory behavior of Atp7a Nes mice reveal requirements for ATP7A that are independent of its role in copper acquisition across the intestine and copper delivery into the brain. The elevated level of dopamine in the brain tissue of Atp7a
Nes mice is consistent with a decrease in D␤H activity due to a lack of ATP7A-dependent copper transport into the secretory pathway. Interestingly, the ratios of catecholamine metabolites (dopamine to norepinephrine and dihydroxyphenylacetic acid to dihydroxyphenylglycine) in Atp7a
Nes mice were normal, in contrast with the elevated ratios reported for infants with Menkes disease and neonatal mo-br mice (7, 18) . However, such differences may reflect the maturity of mice used in the current experiments (7-9 wk) and developmental differences in brain neurochemical concentrations (15) . Elevated dopamine is known to result in hypophagia (40) , and this may in part explain the growth impairment in Atp7a
Nes mice, whose average daily food consumption postweaning was ϳ70% of age-matched WT mice (data not shown). Another secreted copper-dependent enzyme of the nervous system is peptidylglycine ␣-amidating mono- oxygenase. By analogy with D␤H, a deficiency of peptidylglycine ␣-amidating monooxygenase activity caused by a lack of ATP7A-mediated copper transport into the secretory pathway may account for the anxiety phenotype in the Atp7a Nes mice (2). To our knowledge, this study is the first direct demonstration of a role for ATP7A in these processes and suggests that copper transport into the secretory pathway of neurons and/or glia is essential for normal growth, as well as the control of anxiety. Because these phenotypes have not been reported in the mottled mice or patients with Menkes disease, they may be obscured by the more severe neurological phenotypes caused by global ATP7A mutation. Additionally, these phenotypes are not associated with models of dietary copper restriction, underscoring the potential for the Atp7a Nes mice to directly assess new functions of ATP7A in the brain that are not possible with traditional models.
Copper deficiency is a recognized cause of demyelinating neuropathy in animals and humans, including patients with Menkes disease (21, 30, 41) . The finding that the Atp7a Nes mice exhibited normal myelination suggests that the demyelination that occurs in Menkes disease is not a direct consequence of ATP7A loss within the CNS but, rather, a secondary effect of copper deficiency. The motor defects in Atp7a
Nes mice would thus appear to be independent of demyelination and may arise from Cre-mediated loss of Atp7a in motor neurons, which are known to be sensitive to loss of ATP7A (12) .
As noted above, ATP7A has been shown to have a critical role in the availability of an NMDA receptor-dependent, releasable pool of copper in hippocampal neurons (36) . This previous work suggested a unique mechanism linking copper homeostasis and neuronal activation within the CNS, a concept supported by the data reported here that neuronal ATP7A has an essential role in modulating NMDA-dependent seizure activity via regulation of Ca 2ϩ influx. The histological data revealing a marked increase in the presence of dystrophic neurons in the hippocampi of Atp7a
Nes mice 24 h after NMDA administration reveal that ATP7A is protective against NMDA receptor-induced excitotoxicity in vivo and, taken together with observations in mo-br mice (37), reveal a unique relationship between copper homeostasis and NMDA receptor activity of broad relevance to the processes of synaptic plasticity and excitotoxic cell death. Given the proposed role of copper in the pathogenesis of Alzheimer's disease and other cognitive disorders, our findings indicate that the Atp7a Nes mice generated here may be useful in future studies to elucidate the extent to which copper is a regulator of learning and memory via NMDA receptor signaling (47) .
Taken together, the results presented here suggest that the severe neuropathology in the mo-br mice is not due to intrinsic loss of ATP7A within neurons and glia but, rather, to a loss of ATP7A-dependent copper transport into the CNS. Future studies must focus on the role of copper in neuronal function and the precise mechanisms of neuronal cell impairment. The data also identify unique roles for ATP7A within the CNS that may now permit novel therapeutic approaches in reducing excitotoxic cell damage through the manipulation of copper metabolism. As copper is proposed to play a role in a number of neurodegenerative diseases (1, 3, 20, 39) , the Atp7a Nes mice offer the opportunity to directly assess the function of ATP7A in these processes.
